SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001104659-19-060282
Filing Date
2019-11-06
Accepted
2019-11-06 08:30:40
Documents
14
Period of Report
2019-11-06
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K tm1921786d1_8k.htm   iXBRL 8-K 24207
2 EXHIBIT 99.1 tm1921786d1_ex99-1.htm EX-99.1 70153
6 GRAPHIC tm1921786d1_ex99-1img001.jpg GRAPHIC 2409
  Complete submission text file 0001104659-19-060282.txt   282408

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA espr-20191106.xsd EX-101.SCH 3186
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE espr-20191106_lab.xml EX-101.LAB 34591
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE espr-20191106_pre.xml EX-101.PRE 22710
10 EXTRACTED XBRL INSTANCE DOCUMENT tm1921786d1_8k_htm.xml XML 3625
Mailing Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108
Business Address 3891 RANCHERO DRIVE, SUITE 150 ANN ARBOR MI 48108 734-887-3903
Esperion Therapeutics, Inc. (Filer) CIK: 0001434868 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-35986 | Film No.: 191195164
SIC: 2834 Pharmaceutical Preparations